Editors' Pick Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice. Liu M, Wang L, Gao J, Dong Q, Perry G, Ma X, Wang X J Alzheimers Dis. 2019 May 27. PMID: 31156179. Abstract Editors' Pick O-GlcNAcylation of Amyloid-β Protein Precursor by Insulin Signaling Reduces Amyloid-β Production. Kwon OHoon, Cho YYoung, Kim T-W, Chung S J Alzheimers Dis. 2019 May 24. PMID: 31156159. Abstract Editors' Pick Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease. Teunissen CE, Chiu M-J, Yang C-C, Yang S-Y, Scheltens P, Zetterberg H, Blennow K J Alzheimers Dis. 2018; 62(4):1857-1863. PMID: 29614646. Abstract Editors' Pick Association between Hippocampal Shape, Neuroinflammation, and Cognitive Decline in Alzheimer's Disease. Cabinio M, Saresella M, Piancone F, LaRosa F, Marventano I, Guerini F, Nemni R, Baglio F, Clerici M J Alzheimers Dis. 2018; 66(3):1131-1144. PMID: 30400090. Abstract Editors' Pick Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease. Croteau E, Castellano C-A, Richard MAnne, Fortier M, Nugent S, Lepage M, Duchesne S, Whittingstall K, Turcotte ÉE, Bocti C, et al. J Alzheimers Dis. 2018; 64(2):551-561. PMID: 29914035. Abstract Editors' Pick A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment. Wang H, Stewart T, Toledo JB, Ginghina C, Tang L, Atik A, Aro P, Shaw LM, Trojanowski JQ, Galasko DR, et al. J Alzheimers Dis. 2018; 61(4):1541-1553. PMID: 29376878. Abstract Editors' Pick Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease. Ehrenberg AJ, Suemoto CK, Resende Ede Paula F, Petersen C, Leite RElaine Par, Rodriguez RDiehl, Ferretti-Rebustini REloah de L, You M, Oh J, Nitrini R, et al. J Alzheimers Dis. 2018; 66(1):115-126. PMID: 30223398. Abstract Editors' Pick Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, Potempa J, Sculean A, Duning T, Eick S J Alzheimers Dis. 2018; 66(1):105-114. PMID: 30223397. Abstract Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018; 64(s1):S3-S22. PMID: 29562511. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages« first‹ previous123456789…next ›last »
Editors' Pick O-GlcNAcylation of Amyloid-β Protein Precursor by Insulin Signaling Reduces Amyloid-β Production. Kwon OHoon, Cho YYoung, Kim T-W, Chung S J Alzheimers Dis. 2019 May 24. PMID: 31156159. Abstract Editors' Pick Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease. Teunissen CE, Chiu M-J, Yang C-C, Yang S-Y, Scheltens P, Zetterberg H, Blennow K J Alzheimers Dis. 2018; 62(4):1857-1863. PMID: 29614646. Abstract Editors' Pick Association between Hippocampal Shape, Neuroinflammation, and Cognitive Decline in Alzheimer's Disease. Cabinio M, Saresella M, Piancone F, LaRosa F, Marventano I, Guerini F, Nemni R, Baglio F, Clerici M J Alzheimers Dis. 2018; 66(3):1131-1144. PMID: 30400090. Abstract Editors' Pick Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease. Croteau E, Castellano C-A, Richard MAnne, Fortier M, Nugent S, Lepage M, Duchesne S, Whittingstall K, Turcotte ÉE, Bocti C, et al. J Alzheimers Dis. 2018; 64(2):551-561. PMID: 29914035. Abstract Editors' Pick A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment. Wang H, Stewart T, Toledo JB, Ginghina C, Tang L, Atik A, Aro P, Shaw LM, Trojanowski JQ, Galasko DR, et al. J Alzheimers Dis. 2018; 61(4):1541-1553. PMID: 29376878. Abstract Editors' Pick Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease. Ehrenberg AJ, Suemoto CK, Resende Ede Paula F, Petersen C, Leite RElaine Par, Rodriguez RDiehl, Ferretti-Rebustini REloah de L, You M, Oh J, Nitrini R, et al. J Alzheimers Dis. 2018; 66(1):115-126. PMID: 30223398. Abstract Editors' Pick Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, Potempa J, Sculean A, Duning T, Eick S J Alzheimers Dis. 2018; 66(1):105-114. PMID: 30223397. Abstract Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018; 64(s1):S3-S22. PMID: 29562511. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages« first‹ previous123456789…next ›last »
Editors' Pick Plasma Amyloid-β (Aβ42) Correlates with Cerebrospinal Fluid Aβ42 in Alzheimer's Disease. Teunissen CE, Chiu M-J, Yang C-C, Yang S-Y, Scheltens P, Zetterberg H, Blennow K J Alzheimers Dis. 2018; 62(4):1857-1863. PMID: 29614646. Abstract Editors' Pick Association between Hippocampal Shape, Neuroinflammation, and Cognitive Decline in Alzheimer's Disease. Cabinio M, Saresella M, Piancone F, LaRosa F, Marventano I, Guerini F, Nemni R, Baglio F, Clerici M J Alzheimers Dis. 2018; 66(3):1131-1144. PMID: 30400090. Abstract Editors' Pick Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease. Croteau E, Castellano C-A, Richard MAnne, Fortier M, Nugent S, Lepage M, Duchesne S, Whittingstall K, Turcotte ÉE, Bocti C, et al. J Alzheimers Dis. 2018; 64(2):551-561. PMID: 29914035. Abstract Editors' Pick A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment. Wang H, Stewart T, Toledo JB, Ginghina C, Tang L, Atik A, Aro P, Shaw LM, Trojanowski JQ, Galasko DR, et al. J Alzheimers Dis. 2018; 61(4):1541-1553. PMID: 29376878. Abstract Editors' Pick Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease. Ehrenberg AJ, Suemoto CK, Resende Ede Paula F, Petersen C, Leite RElaine Par, Rodriguez RDiehl, Ferretti-Rebustini REloah de L, You M, Oh J, Nitrini R, et al. J Alzheimers Dis. 2018; 66(1):115-126. PMID: 30223398. Abstract Editors' Pick Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, Potempa J, Sculean A, Duning T, Eick S J Alzheimers Dis. 2018; 66(1):105-114. PMID: 30223397. Abstract Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018; 64(s1):S3-S22. PMID: 29562511. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages« first‹ previous123456789…next ›last »
Editors' Pick Association between Hippocampal Shape, Neuroinflammation, and Cognitive Decline in Alzheimer's Disease. Cabinio M, Saresella M, Piancone F, LaRosa F, Marventano I, Guerini F, Nemni R, Baglio F, Clerici M J Alzheimers Dis. 2018; 66(3):1131-1144. PMID: 30400090. Abstract Editors' Pick Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease. Croteau E, Castellano C-A, Richard MAnne, Fortier M, Nugent S, Lepage M, Duchesne S, Whittingstall K, Turcotte ÉE, Bocti C, et al. J Alzheimers Dis. 2018; 64(2):551-561. PMID: 29914035. Abstract Editors' Pick A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment. Wang H, Stewart T, Toledo JB, Ginghina C, Tang L, Atik A, Aro P, Shaw LM, Trojanowski JQ, Galasko DR, et al. J Alzheimers Dis. 2018; 61(4):1541-1553. PMID: 29376878. Abstract Editors' Pick Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease. Ehrenberg AJ, Suemoto CK, Resende Ede Paula F, Petersen C, Leite RElaine Par, Rodriguez RDiehl, Ferretti-Rebustini REloah de L, You M, Oh J, Nitrini R, et al. J Alzheimers Dis. 2018; 66(1):115-126. PMID: 30223398. Abstract Editors' Pick Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, Potempa J, Sculean A, Duning T, Eick S J Alzheimers Dis. 2018; 66(1):105-114. PMID: 30223397. Abstract Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018; 64(s1):S3-S22. PMID: 29562511. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages« first‹ previous123456789…next ›last »
Editors' Pick Ketogenic Medium Chain Triglycerides Increase Brain Energy Metabolism in Alzheimer's Disease. Croteau E, Castellano C-A, Richard MAnne, Fortier M, Nugent S, Lepage M, Duchesne S, Whittingstall K, Turcotte ÉE, Bocti C, et al. J Alzheimers Dis. 2018; 64(2):551-561. PMID: 29914035. Abstract Editors' Pick A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment. Wang H, Stewart T, Toledo JB, Ginghina C, Tang L, Atik A, Aro P, Shaw LM, Trojanowski JQ, Galasko DR, et al. J Alzheimers Dis. 2018; 61(4):1541-1553. PMID: 29376878. Abstract Editors' Pick Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease. Ehrenberg AJ, Suemoto CK, Resende Ede Paula F, Petersen C, Leite RElaine Par, Rodriguez RDiehl, Ferretti-Rebustini REloah de L, You M, Oh J, Nitrini R, et al. J Alzheimers Dis. 2018; 66(1):115-126. PMID: 30223398. Abstract Editors' Pick Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, Potempa J, Sculean A, Duning T, Eick S J Alzheimers Dis. 2018; 66(1):105-114. PMID: 30223397. Abstract Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018; 64(s1):S3-S22. PMID: 29562511. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages« first‹ previous123456789…next ›last »
Editors' Pick A Longitudinal Study of Total and Phosphorylated α-Synuclein with Other Biomarkers in Cerebrospinal Fluid of Alzheimer's Disease and Mild Cognitive Impairment. Wang H, Stewart T, Toledo JB, Ginghina C, Tang L, Atik A, Aro P, Shaw LM, Trojanowski JQ, Galasko DR, et al. J Alzheimers Dis. 2018; 61(4):1541-1553. PMID: 29376878. Abstract Editors' Pick Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease. Ehrenberg AJ, Suemoto CK, Resende Ede Paula F, Petersen C, Leite RElaine Par, Rodriguez RDiehl, Ferretti-Rebustini REloah de L, You M, Oh J, Nitrini R, et al. J Alzheimers Dis. 2018; 66(1):115-126. PMID: 30223398. Abstract Editors' Pick Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, Potempa J, Sculean A, Duning T, Eick S J Alzheimers Dis. 2018; 66(1):105-114. PMID: 30223397. Abstract Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018; 64(s1):S3-S22. PMID: 29562511. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages« first‹ previous123456789…next ›last »
Editors' Pick Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease. Ehrenberg AJ, Suemoto CK, Resende Ede Paula F, Petersen C, Leite RElaine Par, Rodriguez RDiehl, Ferretti-Rebustini REloah de L, You M, Oh J, Nitrini R, et al. J Alzheimers Dis. 2018; 66(1):115-126. PMID: 30223398. Abstract Editors' Pick Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, Potempa J, Sculean A, Duning T, Eick S J Alzheimers Dis. 2018; 66(1):105-114. PMID: 30223397. Abstract Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018; 64(s1):S3-S22. PMID: 29562511. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages« first‹ previous123456789…next ›last »
Editors' Pick Periodontal Pathogens and Associated Intrathecal Antibodies in Early Stages of Alzheimer's Disease. Laugisch O, Johnen A, Maldonado A, Ehmke B, Bürgin W, Olsen I, Potempa J, Sculean A, Duning T, Eick S J Alzheimers Dis. 2018; 66(1):105-114. PMID: 30223397. Abstract Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018; 64(s1):S3-S22. PMID: 29562511. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages« first‹ previous123456789…next ›last »
Editors' Pick Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. Cummings J, Ritter A, Zhong K J Alzheimers Dis. 2018; 64(s1):S3-S22. PMID: 29562511. Abstract Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages« first‹ previous123456789…next ›last »
Editors' Pick Distinct White Matter Changes Associated with Cerebrospinal Fluid Amyloid-β1-42 and Hypertension. Al-Janabi OM, Brown CA, Bahrani AA, Abner EL, Barber JM, Gold BT, Goldstein LB, Murphy RR, Nelson PT, Johnson NF, et al. J Alzheimers Dis. 2018; 66(3):1095-1104. PMID: 30400099. Abstract Pages« first‹ previous123456789…next ›last »
